Sector: MedicalGNTA (OTCBB: GNTA)
Headlines
- Genta Announces Closing of $10 Million in Two Offerings of Common Stock and Convertible Notes
Sep 04, 2009 08:41 PM | GNTA, RODM
- Genta Raises $10 Million in Offering of Common Stock and Convertible Notes
Jul 07, 2009 11:00 AM | GNTA, RODM
- OTC Select Announces Daily Stock Watch
Jun 05, 2009 02:00 PM | GNTA
- Biotech Industry Overview
Jun 01, 2009 10:43 AM | ALKS, AMAG, CRA, CTIC, CYCC, DCGN
- 10 Extreme Trades On Pending Clinical Trial Results
May 14, 2009 11:42 AM | ARNA, CLDA, FOLD, GNTA, INSM, JAZZ
- Biotech Industry - Industry Outlook
Apr 16, 2009 04:59 PM | ALKS, AMAG, CELG, CEPH, CRA, CTIC
- Biotechnology Industry - Zacks Analyst Interviews
Dec 05, 2008 08:49 AM | AMAG, ANDS, AOB, BMRN, CRTX, DCGN
- Biotechnology Industry
Dec 04, 2008 04:10 PM | AMAG, ANDS, AOB, BMRN, CRTX, DCGN
- Analyst Comments: United Thera, Genta, Visteon, Watsco, Autonation, National Semi, Saks, Lehman, Joy Global, Nuvelo, 3D Systems, Suntech Power, Dassault, Cell Therapeutics, Analog Devices, Energy Transfer, General Growth
Aug 20, 2008 04:03 PM | ADI, AN, BBT, CTIC, DASTY, ETP
- Analyst Comments: Agco, AXA Group, SID, Genta, DPL,
Jul 31, 2008 07:00 AM | AG, AXA, DPL, GNTA, SID
- Genta Implements Reverse Stock Split
Jul 13, 2009 07:04 AM | GNTA
- Genta Incorporated Announces Delay in Implementation of Reverse Common Stock Split
Jun 29, 2009 06:22 PM | GNTA
- Board of Directors of Genta Incorporated Announce Reverse Split of Company’s Common Stock
Jun 26, 2009 05:01 PM | GNTA
- Genasense® Combined with Temodar® and Abraxane® Shows Preliminary Evidence of High Response Rates and Extended Survival in Patients with Advanced Melanoma
Jun 03, 2009 08:32 AM | GNTA
- New Clinical Data for Tesetaxel, a Leading Oral Taxane, Show Anticancer Activity and Acceptable Safety in Ongoing Study
Jun 01, 2009 08:37 AM | GNTA
- Genta Incorporated Announces Record Date and Meeting Date for Special Stockholders Meeting
May 28, 2009 05:00 PM | GNTA
- Genta Incorporated Announces Postponement of Special Stockholders Meeting
May 26, 2009 04:52 PM | GNTA
- Independent Data Monitoring Board Recommends Continuation to Completion of Genta’s Phase 3 Trial of Genasense® in Advanced Melanoma
May 19, 2009 08:41 AM | GNTA
- Genta Incorporated Announces First Quarter 2009 Financial Results
May 12, 2009 07:52 AM | GNTA
- Genta Incorporated to Host Conference Call to Discuss First Quarter 2009 Highlights and Financial Results
May 07, 2009 08:48 AM | GNTA
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
GNTA
|
Compare to S&P
|
| YTD |
244.44 %
|
253.90 %
|
| 4 Weeks |
5.68 %
|
13.75 %
|
| 12 Weeks |
45.31 %
|
43.74 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -150.00 %
|
|
EPS Growth in Last Year: 96.55 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -47.01 %
|
|
